Larry Ramer

Larry Ramer

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

Why It’s Time to Buy Digital World Acquisition Stock Again

With President Donald Trump in the news much more and beginning to become involved with the Truth Social app, DWAC stock is a buy once again.

Twitter Stock Has Risks After Deal With Elon Musk

The risk-reward ratio of Twitter and TWTR stock is unfavorable following the company's takeover deal with Tesla CEO Elon Musk.

BIOR Stock Starts Trading as Progenity’s Rebrand Takes Shape. What to Know.

Biora's product is supposed to enable biologics to be delivered directly to GI tracts. BIOR stock is a favorite of retail investors.

Why Is AMC Entertainment (AMC) Stock in the Spotlight Today?

Lifted by several popular movies, AMC's Q1 results meaningfully exceeded expectations, lifting confidence in AMC stock.

Snap’s Q1 Results Were Much Better Than They Looked

Snap's Q1 results were much better than they looked on the surface, while Snap's user base is still growing rapidly. SNAP stock is worth buying.

Why the Decline of Rivian Stock Has Created a Great Buying Opportunity

The fears that have caused RIVN stock to crater are unjustified. As a result, the shares' weakness has created a good buying opportunity.

Bitcoin Price Predictions: Where Will BTC Go Next Amid Crypto Crash?

Despite the recent plunge of Bitcoin and other cryptos, the Bitcoin price predictions of many sector publications and analysts remain bullish.

BNTX Stock Treks Higher on BioNTech’s Vaccine Sales

BNTX stock is climbing on Monday after BioNTech reported better-than-expected results. The company credits Covid-19 vaccine innovation.

The Outlook of SoFi Stock Has Gotten Even Worse

SOFI stock is overvalued and there are too many political risks associated with it to make it investment worthy today.

The Risk-Reward Ratio of QuantumScape Stock Is Unfavorable

Among the negative factors that could badly hurt QS stock are technical problems and progress by QuantumScape's competitors.